IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Corsini, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.353
EU - Europa 2.306
AS - Asia 1.837
SA - Sud America 316
AF - Africa 49
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.287
PL - Polonia 707
SG - Singapore 597
CN - Cina 562
IT - Italia 476
BR - Brasile 273
DE - Germania 272
UA - Ucraina 245
HK - Hong Kong 218
FI - Finlandia 135
GB - Regno Unito 127
VN - Vietnam 125
TR - Turchia 72
RU - Federazione Russa 70
IN - India 61
IE - Irlanda 55
ES - Italia 40
NL - Olanda 36
FR - Francia 34
CA - Canada 33
ID - Indonesia 32
BD - Bangladesh 29
JP - Giappone 29
SE - Svezia 25
BE - Belgio 21
ZA - Sudafrica 21
AR - Argentina 20
MX - Messico 17
IR - Iran 15
CZ - Repubblica Ceca 14
AT - Austria 12
KR - Corea 11
PH - Filippine 10
IQ - Iraq 9
PK - Pakistan 8
TH - Thailandia 8
AU - Australia 7
CH - Svizzera 7
EG - Egitto 7
KG - Kirghizistan 7
MA - Marocco 7
CO - Colombia 6
EC - Ecuador 5
ET - Etiopia 5
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
IL - Israele 4
LK - Sri Lanka 4
MY - Malesia 4
NO - Norvegia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
MU - Mauritius 3
PA - Panama 3
RO - Romania 3
UZ - Uzbekistan 3
CU - Cuba 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.872
Salva come PNG Salva come JPEG
Città #
Warsaw 703
Ashburn 390
Fairfield 314
Singapore 288
Brescia 219
Hong Kong 208
Woodbridge 182
Jacksonville 180
Chandler 177
Ann Arbor 170
Houston 148
Beijing 130
Seattle 111
Cambridge 105
New York 100
Princeton 100
Los Angeles 99
Wilmington 96
Dearborn 71
Helsinki 69
Munich 68
Milan 63
Dallas 56
Dublin 55
Istanbul 53
The Dalles 53
Nanjing 50
Dong Ket 41
San Francisco 40
Buffalo 34
Turku 34
Chicago 31
Ho Chi Minh City 31
Shanghai 31
São Paulo 29
Jakarta 26
Madrid 26
Des Moines 25
Shenyang 24
London 22
Moscow 21
Brussels 20
Tokyo 20
Washington 20
San Diego 19
Santa Clara 18
Hebei 17
Jinan 17
Lancaster 17
Nanchang 17
Redondo Beach 16
Nuremberg 15
Hanoi 14
Phoenix 14
Guangzhou 13
Johannesburg 13
Tianjin 13
Amsterdam 12
Boardman 12
Brooklyn 12
Hangzhou 12
Lappeenranta 12
Orem 12
Changsha 11
Denver 11
Frankfurt am Main 11
Atlanta 10
Boston 10
Brno 10
Fara Gera d'Adda 10
Montreal 10
San Mateo 10
Chennai 9
Council Bluffs 9
Haikou 9
Stockholm 9
Toronto 9
Zhengzhou 9
Ankara 8
Hefei 8
Rio de Janeiro 8
Augusta 7
Bangkok 7
Bishkek 7
Charlotte 7
Kunming 7
Mexico City 7
Paris 7
Rome 7
Chengdu 6
Guarulhos 6
Jiaxing 6
Mumbai 6
Naples 6
Padova 6
Porto Alegre 6
Redwood City 6
Bahir Dar 5
Brasília 5
Buenos Aires 5
Totale 5.298
Salva come PNG Salva come JPEG
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 303
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 275
Claudin3 is localized outside the tight junctions in human carcinomas 272
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 258
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 251
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 210
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 205
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 197
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 185
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 183
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 159
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 158
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 155
VEGFR2 inattivo promuove la crescita tumorale modulando le caratteristiche meccaniche della matrice extra-cellulare 148
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 138
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 138
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 133
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 133
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 126
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 124
Role of VEGFs in metabolic disorders 124
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 124
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 118
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 118
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 115
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 113
Role of inflammation in FGF2-driven angiogenesis 112
Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform 111
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 105
CHICK EMBRYO CAM/mES CELL-DERIVED TERATOMAS: A NOVEL MODEL TO STUDY TUMOR ANGIOGENESIS AND VASCULOGENESIS 101
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 96
Modeling cell motility and receptor dynamics 96
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 95
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 95
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 91
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 86
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 85
The BMP antagonist DRM supports angiogenesis and tumor proression 83
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 83
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop 81
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 80
Alternative method to visualize receptor dynamics in cell membranes 74
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 69
The contribution of obesogenic behavior on global warming 69
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 69
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 66
The D647N mutation of FGFR1 induces ligand-independent receptor activation 63
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 61
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 61
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer. 58
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer 51
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 49
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 46
The impact of adipokines on vascular networks in adipose tissue 35
Protocol for performing angiogenic and tumorigenic assays using the in ovo chick embryo chorioallantoic membrane model 26
Totale 8.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021661 0 0 0 0 0 95 55 117 99 113 103 79
2021/2022471 35 79 11 18 8 27 30 26 30 61 40 106
2022/2023521 79 34 25 36 50 98 6 61 69 7 26 30
2023/2024774 41 43 84 52 44 126 46 58 113 41 25 101
2024/20251.513 47 15 23 233 134 130 138 81 152 97 263 200
2025/20261.675 300 335 217 424 366 33 0 0 0 0 0 0
Totale 8.032